Sergio
Vaño Galván
Profesor/a Asociado/a en CC. de la Salud


Universidade Estadual Paulista
São Paulo, BrasilPublications in collaboration with researchers from Universidade Estadual Paulista (9)
2024
-
Folliculitis decalvans in women: A retrospective multicentre study of 150 patients
Journal of the European Academy of Dermatology and Venereology
-
Prospective evaluation of blood pressure, heart rate, and side effects in hypertensive patients using low-dose oral minoxidil for hair loss
Journal of the American Academy of Dermatology, Vol. 91, Núm. 5, pp. 1011-1012
2023
2021
-
5-alpha-reductase inhibitors are associated with reduced frequency of COVID-19 symptoms in males with androgenetic alopecia
Journal of the European Academy of Dermatology and Venereology
-
Androgenetic alopecia may be associated with weaker COVID-19 T-cell immune response: An insight into a potential COVID-19 vaccine booster
Medical Hypotheses, Vol. 146
-
Anti-androgens may protect against severe COVID-19 outcomes: results from a prospective cohort study of 77 hospitalized men
Journal of the European Academy of Dermatology and Venereology
2020
-
Androgen sensitivity gateway to COVID-19 disease severity
Drug Development Research
-
Novel topical booster enhances follicular sulfotransferase activity in patients with androgenetic alopecia: a new strategy to improve minoxidil response
Journal of the European Academy of Dermatology and Venereology
-
Racial variations in COVID-19 deaths may be due to androgen receptor genetic variants associated with prostate cancer and androgenetic alopecia. Are anti-androgens a potential treatment for COVID-19?
Journal of Cosmetic Dermatology